LifeScience Clinical & Diagnostic
CStone Secures UK MHRA Approval For Sugemalimab In Stage III Non Small Cell Lung Cancer
Following approval by the European Commission (EC), sugemalimab has received a new indication approval from the UK Medicines and Healthcare products...
February 24, 2026 | News
Formosa Pharmaceuticals Signs Exclusive Licensing Agreement With Arrotex For APP13007 In Australia And New Zealand
Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Arrotex Ph...
February 24, 2026 | News
AVEO Oncology Selects Ficlatuzumab Dose for Phase 3 FIERCE-HN Trial in Head and Neck Cancer
– Global enrollment continues in the Phase 3 registrational studyfollowing the planned first interim analysis for patients with HPV-negati...
February 24, 2026 | News
Asahi Kasei Pharma Advances AK1960 Into Phase I For Refractory Kidney Diseases
Asahi Kasei Pharma, a global provider of healthcare and pharmaceutical solutions, in collaboration with Alchemedicine, has announced that its novel Endothe...
February 23, 2026 | News
ANKTIVA Plus BCG Secures European Commission Authorization As First Immunotherapy For BCG Unresponsive NMIBC
ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive blad...
February 20, 2026 | News
Waters Introduces 1 mm I.D. Microflow LC Columns With MaxPeak Premier Technology
Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput...
February 19, 2026 | News
QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology To Expand Global Immunoassay Portfolio
Agreement adds new analyzer platforms and expands assay menu across key international markets QuidelOrtho has entered a long-term strategic supply agreeme...
February 18, 2026 | News
Beactica Therapeutics AB Secures EUR 2.5 Million EIC Grant To Advance Precision Immune Therapy For Glioblastoma
Beactica Therapeutics AB, a Swedish precision medicine company, announced that it, together with leading glioblastoma researchers at KU Leuven, has been aw...
February 18, 2026 | News
P Cure Reports First Prospective Clinical Evidence Supporting Gantry Less Upright Proton Therapy For Lung Cancer Re Irradiation
P-Cure, a supplier of compact, gantry-less proton therapy systems, announced the first-ever prospective clinical results demonstrating the feasibility, saf...
February 18, 2026 | News
Bio Techne Corporation Announces CE IVD Marking For Ella Benchtop Immunoassay Platform In European Union
Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform tha...
February 18, 2026 | News
CStone Pharmaceuticals Secures US FDA IND Clearance For Phase II Trial Of CS2009 In Advanced Solid Tumours
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA...
February 17, 2026 | News
Omics Empower Expands Spatial Transcriptomics Services With Xenium Platform In Hong Kong
Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In S...
February 16, 2026 | News
HanchorBio Secures FDA Orphan Drug Designation For HCB101 In Gastric Cancer
First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnolog...
February 16, 2026 | News
Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...
February 16, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
